Rameda
Egyptian pharmaceutical manufacturer of branded generics, nutraceuticals, food supplements and veterinary products. Operates a purpose-built production complex in 6th of October City with three independent factories and 20 production lines. Activities include multi-formulation manufacturing, toll/contract manufacturing, product registration and export across MENA and Africa, and commercial distribution through private and institutional channels.
Industries
Nr. of Employees
large (251-1000)
Products
Branded generic pharmaceuticals, nutraceuticals, food supplements and veterinary products
A broad portfolio of marketed products across multiple therapeutic areas, including cardiovascular, diabetes, ophthalmology, central nervous system, gastro-intestinal, renal, women’s and men’s health, anti-infectives, analgesics, antivirals, nutraceuticals and veterinary formulations.
Augram 312mg
Broad spectrum antibiotic pharmaceutical product by Rameda.
Augram 228.5mg
Amoxicillin and Clavulanic acid 228.5mg / 5ml powder for oral suspension.
Atrozemb 80-10mg
Lipid-lowering film coated tablets for cardiovascular treatment.
Dapaveldactin 10mg
Diabetes pharmaceutical product by Rameda.
Glybofen 5-1000mg
Diabetes pharmaceutical product by Rameda.
Branded generic pharmaceuticals, nutraceuticals, food supplements and veterinary products
A broad portfolio of marketed products across multiple therapeutic areas, including cardiovascular, diabetes, ophthalmology, central nervous system, gastro-intestinal, renal, women’s and men’s health, anti-infectives, analgesics, antivirals, nutraceuticals and veterinary formulations.
Augram 312mg
Broad spectrum antibiotic pharmaceutical product by Rameda.
Augram 228.5mg
Amoxicillin and Clavulanic acid 228.5mg / 5ml powder for oral suspension.
Atrozemb 80-10mg
Lipid-lowering film coated tablets for cardiovascular treatment.
Dapaveldactin 10mg
Diabetes pharmaceutical product by Rameda.
Glybofen 5-1000mg
Diabetes pharmaceutical product by Rameda.
Services
Third-party manufacturing of pharmaceutical products using available production capacity across solid, liquid, sterile and injectable lines.
Support for product registration and export to MENA and African markets through export agents and in-house registration activities.
Structured training programs for medical representatives combining sales skills with product knowledge.
Third-party manufacturing of pharmaceutical products using available production capacity across solid, liquid, sterile and injectable lines.
Support for product registration and export to MENA and African markets through export agents and in-house registration activities.
Structured training programs for medical representatives combining sales skills with product knowledge.
Expertise Areas
- Pharmaceutical manufacturing for multiple dosage forms (solid, liquid, sterile, injectables)
- Toll and contract manufacturing
- Product registration and market access across MENA and Africa
- Branded-generic portfolio development and commercialization
Key Technologies
- Blow–fill–seal aseptic filling
- Lyophilization (freeze-drying) for vials
- Sterile ophthalmic production
- Solid dosage manufacturing (tablets, capsules, sachets)
News & Updates
Announcement of launch of a lactase enzyme supplement for lactose intolerance.
Quarterly earnings release for Q4 2023.
Launch announcement for a new type 2 diabetes product to expand chronic portfolio.
Announcement of launch of a lactase enzyme supplement for lactose intolerance.
Quarterly earnings release for Q4 2023.
Launch announcement for a new type 2 diabetes product to expand chronic portfolio.